Latest
1681 stories · page 1 of 141
FIVE AT FIVE: Musk floats a $3.5 trillion merger, GSK lands an FDA first and Ashtead agrees a £505 million exit
SpaceX and Tesla as one company, a hepatitis B breakthrough and London recovering its nerve
SpaceX 'rockets' in pre-market trading. Are the bulls delded?
The results blew past expectations, and Wall Street cheered. But there are still issues - not least who is picking the tab for investment
